Angels Partners logo
  • Find Angel Investors
    • Find Angel Investors in the US
    • Find Angel Investors in the UK
    • Find Angel Investors in Europe
      Find Angel Investors in DenmarkFind Angel Investors in FinlandFind Angel Investors in FranceFind Angel Investors in GermanyFind Angel Investors in ItalyFind Angel Investors in NetherlandsFind Angel Investors in SwedenFind Angel Investors in Switzerland
    • Find Angel Investors in Canada
    • Find Angel Investors in Australia
  • Top VC Firms
    Top AI VC firmsTop BioTech VC firmsTop CleanTech VC firmsTop Cyber Security VC firmsTop E-commerce VC firmsTop HealthTech VC firmsTop FinTech VC firmsTop Food Industry VC firmsTop Robotics VC firmsTop SaaS VC firmsTop Transportation VC firms
  • Pricing
  • Products
    Investor CommunityInvestor DatabaseAutomationWarm IntrosFounder CommunityDocument SharingLegal Templates
  • FAQ
  • Blog
  • About
  • Sign up
  • Log in
Are you an

  • Entrepreneur
  • Investor
< Browse Firms
Logo Firm The Longevity Fund
websitelinkedinangellisttwittergoogle

The Longevity Fund

map marker logo San Francisco California - San Francisco Bay Area |  U.S.A.

Investor TypeFirm
Type of FundVC
IndustriesBioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • DeepTech • Healthcare (& Wellness)
StagesPre-Seed, Seed, Series A
InvestingUnited States
Investment Range $100,000  -  $1,000,000
Investment Sweet Spot $500,000

Investors who co-invest with The Longevity Fund

Investors who are part of this firm

About The Fund

The Longevity Fund is a venture capital firm based in San Francisco, California, specializing in investments across the healthcare, therapeutic, pharmaceutical, and biotechnology sectors. With a primary focus on longevity, they target investment opportunities that aim to extend healthy human lifespans through innovative drug development. Founded in 2011 by Laura Deming, The Longevity Fund has pioneered the longevity investment space by funding companies that not only offer financial returns but also bring plausible drug candidates into clinical trials, specifically targeting age-related diseases. As they transition into a new decade, they anticipate a surge of high-caliber founders equipped with adequate resources to develop the first approved longevity drugs, achieve significant biotech valuations, and transform the planning of time and energy for the older demographic. Beyond 2050, they see longevity drug development becoming as mainstream and well-funded as cancer drug development is today. Their investment thesis revolves around the belief that first-time or early-career founders with unconventional backgrounds are better poised to succeed in this new industry thanks to their passion for the mission and ability to think differently. The Longevity Fund argues that counterfactual founders have an advantage in narrative-setting which is crucial for company-building in the longevity sector. Their position is that while Silicon Valley effectively hones the operational skills of first-time founders, these founders are essential for recruiting top drug development talent and for overcoming the traditional hindrances faced in more conventional biotech ecosystems. The Longevity Fund recognizes that regulatory strategies, scientific understanding, fundraising, and company-building in the longevity field will involve unique challenges. Hence, they are placing their bets on founders who envision starting longevity companies and can endure the hardship involved in creating medicines that could grant more healthy living years. The Longevity Fund's deep commitment to this cause is underscored by their core beliefs: longevity is technically possible, economically viable, and desirable. They refute common objections to longevity research by outlining their philosophy — from challenging misconceptions about the inevitability of death due to entropy to expressing confidence in the potential of biotechnology tools to incrementally enhance human lifespans.

The Longevity Fund's investments on record

Fauna Bio  
Rubedo Life Sciences $12,000,000.00 Seed
Clara Health $2,000,000.00 Seed
Tweets by The Longevity Fund

Similar Investment Firms

Similar Investor Shalon Ventures
Shalon Ventures
Similar Investor venBio
venBio
Similar Investor Magnetic Ventures
Magnetic Ventures
Similar Investor Coronis Medical Ventures
Coronis Medical Ventures
Similar Investor Brain Trust Accelerator Fund
Brain Trust Accelerator Fund
Similar Investor Stealth Startup
Stealth Startup
Similar Investor HCI Equity Partners
HCI Equity Partners
Similar Investor New Horizons Venture Capital
New Horizons Venture Capital
Similar Investor 3Si Venture Capital
3Si Venture Capital
angels partners Overview

Contact over 100,000 investors!

Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.

With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.

View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.

e We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.

 

Register to become visible to a large community of investors on our platform.

  • Sign up
  • Log in
  • Prime Founders
  • 85 Great Portland St.
  • London, U.K.
  •   contact@angelspartners.com
  • About Us
  • Terms & Conditions
  • Privacy Policy
  • Editorial Process
  • Contact Us
Copyright © 2024 - All trademarks and copyrights belong to their respective owners.
proof notifcation
32 New StartupsStarted their fundraisingover the last 7 daysproof logo